Skip to main content
. 2022 Sep 14;107(12):3287–3301. doi: 10.1210/clinem/dgac517

Figure 1.

Figure 1.

Patient disposition and main analysis cohorts. Baseline prepubertal percentages were based on the number of patients with available puberty status data; n = 72 355; 23 246; 49 109; and 7911 for the safety, excluded, efficacy, and NAH sets, respectively. KIGS, Kabi/Pfizer International Growth Database; NAH, near adult height; rhGH, recombinant human growth hormone.